Gut bacteria linked to immunotherapy success in melanoma patients

Researchers at The George Washington University, working with Weill Cornell Medicine, have identified specific gut bacteria linked to better responses to cancer immunotherapy in patients with advanced melanoma. The study analyzed data from 678 patients across seven previous studies, all treated with immune checkpoint inhibitors—a type of therapy that can be highly effective in treating certain cancers, but does not work for everyone.